Showing results (31-40 of 307) with videos related to
Sort By:
Pageof 31
Geriatrics|September 23, 2006
Long-term care of Parkinson's disease. Strategies for managing "wearing off" symptom re-emergence and dyskinesiasRobert A HauserParkinsonism & Related Disorders|January 20, 2010
New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategyRobert A HauserThe International Journal of Neuroscience|November 1, 2011
Future treatments for Parkinson's disease: surfing the PD pipelineRobert A HauserThe American Journal of Managed Care|March 20, 2010
Early pharmacologic treatment in Parkinson's diseaseRobert A HauserJAMA Neurology|June 13, 2017
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical TrialRajesh Pahwa, Caroline M Tanner, Robert A Hauser, et al.Journal of Parkinson'S Disease|February 8, 2021
Impact of DaTscan Imaging on Clinical Decision Making in Clinically Uncertain Parkinson's DiseaseJonathan R Isaacson, Salima Brillman, Nisha Chhabria, et al.Neurodegenerative Disease Management|December 23, 2022
Motor response with apomorphine sublingual film and levodopa in patients with OFF episodesStuart H Isaacson, Alyssa Bowling, Ian Zhang, et al.Current Neurology and Neuroscience Reports|March 9, 2021
Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic HypotensionStuart H Isaacson, Khashayar Dashtipour, Ali A Mehdirad, et al.Clinical Parkinsonism & Related Disorders|May 21, 2024
Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosisStuart H Isaacson, Rajesh Pahwa, Fernando Pagan, et al.Clinical Parkinsonism & Related Disorders|January 24, 2023
How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literatureStuart H Isaacson, Richard B Dewey, Rajesh Pahwa, et al.Pageof 31